Siege Pharmaceuticals develops cancer drugs based on a naturally occurring molecule that starves cancer cells to death. Its synthetic variants with optimized drug-like properties are based on a naturally occurring molecule and target multiple pathways that cancer cells need for growth, thereby enabling medical practitioners to control the growth